About Shugoshin 1
Shugoshin 1 (SGO1) is a protein
from Homo sapiens identified by UniProt accession
Q5FBB7, 561 residues long.
MolForge cross-references it against 0 known binders and
115 disease associations.
Target properties
| Protein name | Shugoshin 1 |
| UniProt accession | Q5FBB7 |
| Gene | SGO1 |
| Organism | Homo sapiens |
| Length | 561 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (115)
Diseases linked to this target (Open Targets).
- chronic atrial and intestinal dysrhythmia · score 0.54
- mean corpuscular volume · score 0.38
- mathematical ability · score 0.36
- body fat percentage · score 0.33
- body mass index · score 0.31
- lean body mass · score 0.28
- mean corpuscular hemoglobin concentration · score 0.28
- attention deficit hyperactivity disorder · score 0.27
- health study participation · score 0.26
- fat body mass · score 0.24
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q5FBB7-F1 | alphafold | PREDICTED | 55.11 | — |
Amino-acid sequence (561 residues)
MAKERCLKKS FQDSLEDIKK RMKEKRNKNL AEIGKRRSFI AAPCQIITNT STLLKNYQDN NKMLVLALEN EKSKVKEAQD IILQLRKECY YLTCQLYALK GKLTSQQTVE PAQNQEICSS GMDPNSDDSS RNLFVKDLPQ IPLEETELPG QGESFQIEDQ IPTIPQDTLG VDFDSGEAKS TDNVLPRTVS VRSSLKKHCN SICQFDSLDD FETSHLAGKS FEFERVGFLD PLVNMHIPEN VQHNACQWSK DQVNLSPKLI QPGTFTKTKE DILESKSEQT KSKQRDTQER KREEKRKANR RKSKRMSKYK ENKSENKKTV PQKKMHKSVS SNDAYNFNLE EGVHLTPFRQ KVSNDSNREE NNESEVSLCE SSGSGDDSDD LYLPTCKYIQ NPTSNSDRPV TRPLAKRALK YTDEKETEGS KPTKTPTTTP PETQQSPHLS LKDITNVSLY PVVKIRRLSL SPKKNKASPA VALPKRRCTA SVNYKEPTLA SKLRRGDPFT DLCFLNSPIF KQKKDLRRSK KRALEVSPAK EAIFILYYVR EFVSRFPDCR KCKLETHICL R
Explore Shugoshin 1 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets